{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T17:30:02Z","timestamp":1780594202695,"version":"3.54.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T00:00:00Z","timestamp":1524528000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s00393-018-0446-1","type":"journal-article","created":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T12:26:36Z","timestamp":1524572796000},"page":"363-368","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["\u00c4lter werden mit axialer Spondyloarthritis","Becoming older with axial spondyloarthritis"],"prefix":"10.1007","volume":"77","author":[{"given":"U.","family":"Kiltz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Baraliakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Buehring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,24]]},"reference":[{"key":"446_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31591-4","author":"J Sieper","year":"2017","unstructured":"Sieper J, Poddubnyy D (2017) Axial spondyloarthritis. Lancet. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(16)31591-4","journal-title":"Lancet"},{"issue":"5","key":"446_CR2","doi-asserted-by":"publisher","first-page":"R125","DOI":"10.1186\/ar2537","volume":"10","author":"H Appel","year":"2008","unstructured":"Appel H, Janssen L, Listing J, Heydrich R, Rudwaleit M, Sieper J (2008) Serum levels of biomarkers of bone and cartilage destruction and new bone formation in different cohorts of patients with axial spondyloarthritis with and without tumor necrosis factor-alpha blocker treatment. Arthritis Res Ther 10(5):R125","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"446_CR3","doi-asserted-by":"publisher","first-page":"R108","DOI":"10.1186\/ar3833","volume":"14","author":"E Klingberg","year":"2012","unstructured":"Klingberg E, Lorentzon M, Mellstrom D, Geijer M, Gothlin J, Hilme E et\u00a0al (2012) Osteoporosis in ankylosing spondylitis\u2014prevalence, risk factors and methods of assessment. Arthritis Res Ther 14(3):R108","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"446_CR4","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s11926-012-0270-6","volume":"14","author":"MT Nurmohamed","year":"2012","unstructured":"Nurmohamed MT, van der Horst-Bruinsma I, Maksymowych WP (2012) Cardiovascular and cerebrovascular diseases in ankylosing spondylitis: current insights. Curr Rheumatol Rep 14(5):415\u2013421","journal-title":"Curr Rheumatol Rep"},{"issue":"11","key":"446_CR5","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1136\/ard.2011.151191","volume":"70","author":"G Bakland","year":"2011","unstructured":"Bakland G, Gran JT, Nossent JC (2011) Increased mortality in ankylosing spondylitis is related to disease activity. Ann Rheum Dis 70(11):1921\u20131925","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"446_CR6","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1136\/annrheumdis-2015-207688","volume":"75","author":"S Exarchou","year":"2016","unstructured":"Exarchou S, Lie E, Lindstrom U, Askling J, Forsblad-d\u2019Elia H, Turesson C et al (2016) Mortality in ankylosing spondylitis: results from a\u00a0nationwide population-based study. Ann Rheum Dis 75(8):1466. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2015-207688","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"446_CR7","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1136\/ard.2008.100503","volume":"68","author":"D Vosse","year":"2009","unstructured":"Vosse D, Landewe R, van der Heijde D, van der Linden S, van Staa TP, Geusens P (2009) Ankylosing spondylitis and the risk of fracture: results from a\u00a0large primary care-based nested case-control study. Ann Rheum Dis 68(12):1839\u20131842","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"446_CR8","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/rheumatology\/kev332","volume":"55","author":"K Briot","year":"2016","unstructured":"Briot K, Etcheto A, Miceli-Richard C, Dougados M, Roux C (2016) Bone loss in patients with early inflammatory back pain suggestive of spondyloarthritis: results from the prospective DESIR cohort. Rheumatology (Oxford) 55(2):335\u2013342","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"446_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/rheumatology\/39.1.85","volume":"39","author":"D Mitra","year":"2000","unstructured":"Mitra D, Elvins DM, Speden DJ, Collins AJ (2000) The prevalence of vertebral fractures in mild ankylosing spondylitis and their relationship to bone mineral density. Rheumatology (Oxford) 39(1):85\u201389","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"446_CR10","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1097\/BOR.0b013e3283620777","volume":"25","author":"N Davey-Ranasinghe","year":"2013","unstructured":"Davey-Ranasinghe N, Deodhar A (2013) Osteoporosis and vertebral fractures in ankylosing spondylitis. Curr Opin Rheumatol 25(4):509\u2013516","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"446_CR11","first-page":"310","volume":"35","author":"K Briot","year":"2008","unstructured":"Briot K, Roux C, Gossec L, Charni N, Kolta S, Dougados M et\u00a0al (2008) Effects of etanercept on serum biochemical markers of cartilage metabolism in patients with spondyloarthropathy. J\u00a0Rheumatol 35(2):310\u2013314","journal-title":"J Rheumatol"},{"issue":"10","key":"446_CR12","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.3899\/jrheum.121417","volume":"40","author":"A Durnez","year":"2013","unstructured":"Durnez A, Paternotte S, Fechtenbaum J, Landewe RB, Dougados M, Roux C et al (2013) Increase in bone density in patients with spondyloarthritis during anti-tumor necrosis factor therapy: 6\u2011year followup study. J\u00a0Rheumatol 40(10):1712\u20131718","journal-title":"J Rheumatol"},{"issue":"4","key":"446_CR13","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1136\/ard.62.4.347","volume":"62","author":"F Allali","year":"2003","unstructured":"Allali F, Breban M, Porcher R, Maillefert JF, Dougados M, Roux C (2003) Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor alpha. Ann Rheum Dis 62(4):347\u2013349","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"446_CR14","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3899\/jrheum.150857","volume":"43","author":"MA Weijden van der","year":"2016","unstructured":"van der Weijden MA, van Denderen JC, Lems WF, Nurmohamed MT, Dijkmans BA, van der Horst-Bruinsma IE (2016) Etanercept increases bone mineral density in ankylosing spondylitis, but does not prevent vertebral fractures: results of a\u00a0Prospective Observational Cohort Study. J\u00a0Rheumatol 43(4):758\u2013764","journal-title":"J Rheumatol"},{"issue":"Suppl 2","key":"446_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00393-014-1444-6","volume":"73","author":"U Kiltz","year":"2014","unstructured":"Kiltz U, Oberschelp U, Schneider E, Swoboda B, Bohm H, Winking M et\u00a0al (2014) German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew\u2019s disease and early forms: 8.6 Invasive therapy. Z\u00a0Rheumatol 73(Suppl 2):97\u2013100","journal-title":"Z Rheumatol"},{"issue":"2","key":"446_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00586-008-0764-0","volume":"18","author":"LA Westerveld","year":"2009","unstructured":"Westerveld LA, Verlaan JJ, Oner FC (2009) Spinal fractures in patients with ankylosing spinal disorders: a\u00a0systematic review of the literature on treatment, neurological status and complications. Eur Spine\u00a0J 18(2):145\u2013156","journal-title":"Eur Spine J"},{"issue":"2","key":"446_CR17","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s00223-017-0274-3","volume":"101","author":"C Pray","year":"2017","unstructured":"Pray C, Feroz NI, Nigil Haroon N (2017) Bone mineral density and fracture risk in ankylosing spondylitis: a meta-analysis. Calcif Tissue Int 101(2):182\u2013192","journal-title":"Calcif Tissue Int"},{"key":"446_CR18","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s13075-015-0809-9","volume":"17","author":"P Geusens","year":"2015","unstructured":"Geusens P, De Winter L, Quaden D, Vanhoof J, Vosse D, van den Bergh J et\u00a0al (2015) The prevalence of vertebral fractures in spondyloarthritis: relation to disease characteristics, bone mineral density, syndesmophytes and history of back pain and trauma. Arthritis Res Ther 17:294","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"446_CR19","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/acr.22980","volume":"69","author":"F Maas","year":"2017","unstructured":"Maas F, Spoorenberg A, van der Slik BP, van der Veer E, Brouwer E, Bootsma H et\u00a0al (2017) Clinical risk factors for the presence and development of vertebral fractures in patients with ankylosing spondylitis. Arthritis Care Res 69(5):694. \n                    https:\/\/doi.org\/10.1002\/acr.22980","journal-title":"Arthritis Care Res"},{"issue":"6","key":"446_CR20","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","volume":"76","author":"D Heijde van der","year":"2017","unstructured":"van der Heijde D, Ramiro S, Landewe R, Baraliakos X, Van den Bosch F, Sepriano A et al (2017) 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis 76(6):978\u2013991","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 2","key":"446_CR21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s00393-014-1428-6","volume":"73","author":"U Kiltz","year":"2014","unstructured":"Kiltz U, Rudwaleit M, Sieper J, Krause D, Chenot JF, Stallmach A et\u00a0al (2014) German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew\u2019s disease and early forms: 3 Clinical symptoms. Z\u00a0Rheumatol 73(Suppl 2):28\u201339","journal-title":"Z Rheumatol"},{"issue":"5","key":"446_CR22","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/rheumatology\/39.5.497","volume":"39","author":"HC Murray","year":"2000","unstructured":"Murray HC, Elliott C, Barton SE, Murray A (2000) Do patients with ankylosing spondylitis have poorer balance than normal subjects? Rheumatology (Oxford) 39(5):497\u2013500","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"446_CR23","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.clinbiomech.2011.10.016","volume":"27","author":"ME Vergara","year":"2012","unstructured":"Vergara ME, O\u2019Shea FD, Inman RD, Gage WH (2012) Postural control is altered in patients with ankylosing spondylitis. Clin Biomech 27(4):334\u2013340","journal-title":"Clin Biomech"},{"issue":"8","key":"446_CR24","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1136\/ard.2004.028670","volume":"64","author":"K Briot","year":"2005","unstructured":"Briot K, Garnero P, Le Henanff A, Dougados M, Roux C (2005) Body weight, body composition, and bone turnover changes in patients with spondyloarthropathy receiving anti-tumour necrosis factor {alpha} treatment. Ann Rheum Dis 64(8):1137\u20131140","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"446_CR25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/acr.20566","volume":"64","author":"G Plasqui","year":"2012","unstructured":"Plasqui G, Boonen A, Geusens P, Kroot EJ, Starmans M, van der Linden S (2012) Physical activity and body composition in patients with ankylosing spondylitis. Arthritis Care Res (Hoboken) 64(1):101\u2013107","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"446_CR26","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12891-016-1155-z","volume":"17","author":"A Maghraoui El","year":"2016","unstructured":"El Maghraoui A, Ebo\u2019o FB, Sadni S, Majjad A, Hamza T, Mounach A (2016) Is there a\u00a0relation between pre-sarcopenia, sarcopenia, cachexia and osteoporosis in patients with ankylosing spondylitis? BMC Musculoskelet Disord 17:268","journal-title":"BMC Musculoskelet Disord"},{"issue":"4","key":"446_CR27","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.jocd.2015.04.010","volume":"18","author":"MH Edwards","year":"2015","unstructured":"Edwards MH, Buehring B (2015) Novel approaches to the diagnosis of sarcopenia. J\u00a0Clin Densitom 18(4):472\u2013477","journal-title":"J Clin Densitom"},{"issue":"6","key":"446_CR28","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/art.23719","volume":"59","author":"JT Giles","year":"2008","unstructured":"Giles JT, Ling SM, Ferrucci L, Bartlett SJ, Andersen RE, Towns M et\u00a0al (2008) Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapies. Arthritis Rheum 59(6):807\u2013815","journal-title":"Arthritis Rheum"},{"issue":"2","key":"446_CR29","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.berh.2017.11.007","volume":"31","author":"N Fuggle","year":"2017","unstructured":"Fuggle N, Shaw S, Dennison E, Cooper C (2017) Sarcopenia. Best Pract Res Clin Rheumatol 31(2):218\u2013242","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"446_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejim.2016.07.021","volume":"35","author":"M Cesari","year":"2016","unstructured":"Cesari M, Nobili A, Vitale G (2016) Frailty and sarcopenia: from theory to clinical implementation and public health relevance. Eur J Intern Med 35:1\u20139","journal-title":"Eur J Intern Med"},{"issue":"4","key":"446_CR31","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00223-015-0022-5","volume":"98","author":"JE Morley","year":"2016","unstructured":"Morley JE (2016) Pharmacologic options for the treatment of sarcopenia. Calcif Tissue Int 98(4):319\u2013333","journal-title":"Calcif Tissue Int"},{"key":"446_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s00391-017-1283-6","author":"D Schoene","year":"2017","unstructured":"Schoene D, Kiesswetter E, Sieber CC, Freiberger E (2017) Musculoskeletal factors, sarcopenia and falls in old age. Z\u00a0Gerontol Geriatr. \n                    https:\/\/doi.org\/10.1007\/s00391-017-1283-6\n                    \n                  . [Epub ahead of print]","journal-title":"Z Gerontol Geriatr"},{"issue":"2","key":"446_CR33","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/RHU.0000000000000216","volume":"21","author":"N Dursun","year":"2015","unstructured":"Dursun N, Sarkaya S, Ozdolap S, Dursun E, Zateri C, Altan L et\u00a0al (2015) Risk of falls in patients with ankylosing spondylitis. J\u00a0Clin Rheumatol 21(2):76\u201380","journal-title":"J Clin Rheumatol"},{"issue":"2","key":"446_CR34","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1136\/annrheumdis-2016-209315","volume":"76","author":"JK Eriksson","year":"2017","unstructured":"Eriksson JK, Jacobsson L, Bengtsson K, Askling J (2017) Is ankylosing spondylitis a\u00a0risk factor for cardiovascular disease, and how do these risks compare with those in rheumatoid arthritis? Ann Rheum Dis 76(2):364. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2016-209315","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"446_CR35","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13075-017-1315-z","volume":"19","author":"K Bengtsson","year":"2017","unstructured":"Bengtsson K, Forsblad-d\u2019Elia H, Lie E, Klingberg E, Dehlin M, Exarchou S et al (2017) Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study. Arthritis Res Ther 19(1):102","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"446_CR36","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/acr.20408","volume":"63","author":"A Bremander","year":"2011","unstructured":"Bremander A, Petersson IF, Bergman S, Englund M (2011) Population-based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis. Arthritis Care Res (Hoboken) 63(4):550\u2013556","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"446_CR37","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3899\/jrheum.090667","volume":"37","author":"MJ Peters","year":"2010","unstructured":"Peters MJ, van Eijk IC, Smulders YM, Serne E, Dijkmans BA, van der Horst-Bruinsma IE et al (2010) Signs of accelerated preclinical atherosclerosis in patients with ankylosing spondylitis. J\u00a0Rheumatol 37(1):161\u2013166","journal-title":"J Rheumatol"},{"issue":"4","key":"446_CR38","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/acr.20364","volume":"63","author":"S Mathieu","year":"2011","unstructured":"Mathieu S, Gossec L, Dougados M, Soubrier M (2011) Cardiovascular profile in ankylosing spondylitis: a\u00a0systematic review and meta-analysis. Arthritis Care Res (Hoboken) 63(4):557\u2013563","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"446_CR39","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.semarthrit.2014.10.007","volume":"44","author":"S Mathieu","year":"2015","unstructured":"Mathieu S, Pereira B, Soubrier M (2015) Cardiovascular events in ankylosing spondylitis: an updated meta-analysis. Semin Arthritis Rheum 44(5):551\u2013555","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"446_CR40","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","volume":"76","author":"R Agca","year":"2017","unstructured":"Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJ et\u00a0al (2017) EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update. Ann Rheum Dis 76(1):17\u201328","journal-title":"Ann Rheum Dis"},{"issue":"9894","key":"446_CR41","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0140-6736(13)60900-9","volume":"382","author":"N Bhala","year":"2013","unstructured":"Coxib and traditional NSAID Trialists\u2019 (CNT), Bhala N, Emberson J, Merhi A, Abramson S et al (2013) Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet 382(9894):769\u2013779","journal-title":"Lancet"},{"issue":"5","key":"446_CR42","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1136\/ard.2010.128660","volume":"70","author":"G Burmester","year":"2011","unstructured":"Burmester G, Lanas A, Biasucci L, Hermann M, Lohmander S, Olivieri I et al (2011) The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a\u00a0multidisciplinary European expert panel. Ann Rheum Dis 70(5):818\u2013822","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"446_CR43","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/acr.21596","volume":"64","author":"MC Hochberg","year":"2012","unstructured":"Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J et\u00a0al (2012) American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken) 64(4):465\u2013474","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-018-0446-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-018-0446-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-018-0446-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T23:05:54Z","timestamp":1556060754000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-018-0446-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,24]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["446"],"URL":"https:\/\/doi.org\/10.1007\/s00393-018-0446-1","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,24]]},"assertion":[{"value":"24 April 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"U.\u00a0Kiltz, X.\u00a0Baraliakos, B.\u00a0Buehring und J.\u00a0Braun geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}